Great News
Especially as PAA do not need to Develop the actual drug, MPL just requires Orphan Drug Designation and then the FDA can Monitor an open Commercial Phase 3 Trial..
Tick Tock the Money clock never stops... NZT
Ann: Additional Phase 1 data suggest MPL may inhibit MND, page-319
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 16.5¢ | $189.8K | 1.110M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 81105 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 126000 | 2 |
View Market Depth
| Last trade - 15.48pm 15/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |